Category Archives: oud

Alkermes Hits Two-Year Low On Depression Drug Failure

Shares of drugmaker Alkermes (ALKS) plunged Thursday after the company’s depression drug failed two late-stage trials, though the company claimed it still saw positive signals. Alkermes ran two clinical trials, Forward-3 and Forward-4, comparing its drug ALKS 5461 to a placebo at two dose levels, 2mg and 0.5mg. Neither achieved its endpoint of statistically significant improvement based on the Montgomery — Asberg Depression Rating Scale (MADRS)

Alphabet, Apple In Tech Health Care ‘Convergence’

Lillian Ablon is a “good hacker.” But for every Ablon, there’s a Walter White of cybercrime — a professional bad guy waiting in the wings. In 2013, Ablon was named Deadliest Social Engineer after she digitally busted a Fortune Top 10 company during the DEF CON 21 game of social engineer cyber capture the flag. She was the first woman to earn a coveted DEF CON black badge for social engineering. But what if you put Ablon’s tools in the hands of

Facebook, Palo Alto Lead 5 Growth Champs Into Earnings

Facebook (FB), Palo Alto Networks (PANW) and Universal Display Corp. (OLED), a rumored future Apple (AAPL) supplier, are part of IBD’s Screen of the Day — Top Fundamentals, which includes companies with three-year EPS and sales growth rates of 25% or more. This article is going to look at these long-term growth winners, with a secondary sort based on expected earnings growth for the latest quarter. Along with Five Below (FIVE),iKang Healthcare